Biobank SLICC PI: DR. MURRAY UROWITZ The SLICC group has made a significant commitment to building the world’s largest biorepository of DNA, plasma and serum on an extremely well phenotyped inception cohort of SLE patients. DNA is collected at patient enrolment and serum and plasma samples are collected annually. Our cohort consists of 1835 patients […]
Economic evaluation of lupus nephritis and damage accrual in the SLICC inception cohort SLICC PI: DR. ANN CLARKE New Investigators: Dr. Megan Barber (Rheumatology Fellow, University of Calgary); Dr. May Choi (Rheumatology Fellow, University of Calgary) Funding Source: UCB, Bristol-Myers Squibb The objectives of this study are to estimate the long-term economic costs of: 1) […]
Clinical outcomes and quality of life in lupus nephritis Studies in a prospective, international, inception cohort study SLICC PI: DR. JOHN G. HANLY Funding Source: Bristol-Myers Squibb The objective of this study is to develop models for lupus nephritis (LN) based on the analysis of longitudinal data from the Systemic Lupus International Collaborating Clinics (SLICC) […]
Studies of Damage in the SLICC Inception Cohort SLICC PIs: Dr. Ian Bruce, Dr. John G. Hanly, Dr. Murray Urowitz, Dr. Susan Manzi, Dr. Ann Clarke, Dr.Vern Farewell New Investigators: Dr. Aidan O’Keefe (Post-doctoral statistician) University of Cambridge and Dr. Jayne Little (Clinical MPhil Fellow) University of Manchester Funding Source: Human Genome Sciences / Glaxo […]
Studies of Metabolic Syndrome in the SLICC Inception Cohort Lead Investigators: IN Bruce, MB Urowitz, DD Gladman New Investigator: Dr Ben Parker (Arthritis Research UK Clinical PhD Fellow): University of Manchester Funding Source: Canadian Institute for Health Research, Arthritis Research UK and National Institute for Health Research (UK) The metabolic syndrome (MetS) may contribute to […]
SLICC PI: DR. John G. Hanly An international, multi-center, prospective, inception cohort study of neuropsychiatric systemic lupus erythematosus (NPSLE) Funding Source: Canadian Institute for Health Research The primary objective of this study is to define (1). The long-term significance of NP events attributed to SLE and non-SLE causes in the SLICC inception cohort using patient […]
SLICC PI: Dr. Murray Urowitz Funding Source: Canadian Institute for Health Research The SLICC Registry for Atherosclerosis (RAS) in SLE, directed by Dr. Urowitz, was established by the SLICC group in 2000 with the overall goals to: Determine the incidence, prevalence and nature of atherosclerotic coronary artery disease (CAD) in SLE. Identify associated risk factors […]